Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polypill in High Cardiovascular Risk (SPACE)
NCT01313702Phase 3Withdrawn
- Sponsor
- HCor
- Start
- Oct 2012
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, simvastatin, lisinopril, atenolol, hydrochlorothiazide in cardiovascular disease (CVD), sponsored by HCor. Planned start Oct 2012; status: withdrawn.
02
Drugs
aspirinsimvastatinlisinoprilatenololhydrochlorothiazide
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01313702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313702.